Lithium Hydroxide → N-Methyl-5-oxazol-2-yl-N-propyl-isophthalamic acid
Reaktionsgleichung
C[O:2][C:3](=[O:22])[C:4]1[CH:16]=[C:15]([C:17]2[O:18][CH:19]=[CH:20][N:21]=2)[CH:14]=[C:6]([C:7]([N:9]([CH3:13])[CH2:10][CH2:11][CH3:12])=[O:8])[CH:5]=1.[OH-].[Li+]>C1COCC1>[CH3:13][N:9]([CH2:10][CH2:11][CH3:12])[C:7](=[O:8])[C:6]1[CH:5]=[C:4]([CH:16]=[C:15]([C:17]2[O:18][CH:19]=[CH:20][N:21]=2)[CH:14]=1)[C:3]([OH:22])=[O:2]Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
Stir a solution of N-methyl-5-oxazol-2-yl-N-propyl-isophthalamic acid methyl ester (225 mg, 0.74 mmol) in 1 N lithium hydroxide (3.0 mL, 3.0 mmol) and THF (3.0 mL) at room temperature for 3 h. Add water (40 mL) and extract with ethyl acetate (40 mL). Acidify the aqueous with 5 N HCl, extract with ethyl acetate (2×40 mL), dry (magnesium sulfate) and concentrate to give the title compound (213 mg, 100%).
Aufarbeitung
- extractionAdd water (40 mL) and extract with ethyl acetate (40 mL)
- extractionextract with ethyl acetate (2×40 mL)
- dry with materialdry (magnesium sulfate)
- concentrationconcentrate
Quellen und Nachweise
- ORD-Eintrag
- ord-8b8b7dc7bb2d44d9a4fa260ec39dc953
- Quelldatensatz
- uspto-grants-2009_09
- Patentnummer
- US07585885B2
Notizen zur Reaktion
Wird geladen…